arrow
M

Mairéad G. McNamara

University of Manchester
H指数:42
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Controversies in NEN: An ENETS position statement on the role of liver transplantation (LT) in patients with advanced small-intestinal and pancreatic NETs

神经内分泌肿瘤领域的争议:ENETS关于肝脏移植在晚期小肠和胰腺神经内分泌肿瘤患者中作用的位置声明

2026-10-010
OAAI
Real-world data from patients treated with chemotherapy for biliary tract cancer: insights from a prognostic model. ☆

真实世界数据:化疗治疗胆道癌患者的预后模型分析<sup><em>☆</em></sup>

2026-09-220
OA
EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer

EORTC-1607-GITCG/ABC-09:西吉姆联合帕博利珠单抗治疗晚期或转移性胆道癌的开放标签、单臂II期首线研究

2026-08-010
PRE
BJS commission on the surgical management of pancreatic neuroendocrine tumours

美国外科医师学会胰腺神经内分泌肿瘤外科管理委员会

BJS
IF0
2026-03-170
OA
Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract

神经内分泌肿瘤(NEN)中的争议:ENETS关于胃肠胰道G3分化良好的神经内分泌肿瘤患者治疗立场声明

2025-08-090
OAAI
ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine

ABC-12:探索度伐利尤单抗(MEDI4736)联合顺铂/吉西他滨一线治疗晚期胆道癌患者中的微生物组

2025-07-290
PRE
Impact of mild hypercapnia in critically ill patients with metabolic acidosis

轻度高碳酸血症对重症代谢性酸中毒患者的影响

2025-02-010
OAAI
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
2024-08-0115
PRE
Somatostatin Receptor Imaging with [18F]FET-βAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study
2024-02-082
OAAI
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
2023-09-257
OA
Sodium Bicarbonate for Metabolic Acidosis in the ICU: Results of a Pilot Randomized Double-Blind Clinical Trial

ICU中代谢性酸中毒的碳酸氢钠: 一项随机双盲临床试验的结果

2023-06-092
PRE
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma

NET-02: ni-iri/5-FU或多西他赛作为进行性低分化肺外神经内分泌癌患者二线治疗的随机,非比较,II期试验

2023-06-018
OAAI